WMSA
NVS icon

Weiss Multi-Strategy Advisers’s Novartis NVS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,077
Closed -$1.99M – 594
2020
Q1 		$1.99M Buy
24,077
+3,077
+15% +$275K 0.08% 252
2019
Q4 		$1.99M Buy
21,000
+1,000
+5% +$89.7K 0.03% 422
2019
Q3 		$1.74M Sell
20,000
-5,000
-20% -$449K 0.04% 396
2019
Q2 		$2.28M Buy
25,000
+8,260
+49% +$699K 0.06% 290
2019
Q1 		$1.44M Buy
16,740
+4,464
+36% +$358K 0.04% 363
2018
Q4 		$944K Buy
12,276
+2,482
+25% +$193K 0.04% 303
2018
Q3 		$756K Buy
9,794
+42
+0.4% +$3.1K 0.02% 417
2018
Q2 		$660K Buy
9,752
+824
+9% +$56.9K 0.02% 472
2018
Q1 		$647K Buy
8,928
+1,116
+14% +$85K 0.02% 454
2017
Q4 		$588K Buy
7,812
+3,906
+100% +$295K 0.02% 487
2017
Q3 		$300K Buy
3,906
+36
+0.9% +$2.72K 0.01% 454
2017
Q2 		$289K Sell
3,870
-36
-0.9% -$2.55K 0.01% 481
2017
Q1 		$260K Hold
3,906
– – 0.01% 510
2016
Q4 		$255K Hold
3,906
– – 0.01% 372
2016
Q3 		$276K Sell
3,906
-162
-4% -$11.8K 0.02% 380
2016
Q2 		$301K Sell
4,068
-12,672
-76% -$875K 0.02% 352
2016
Q1 		$1.09M Hold
16,740
– – 0.05% 329
2015
Q4 		$1.29M Sell
16,740
-5,580
-25% -$443K 0.09% 216
2015
Q3 		$1.84M Hold
22,320
– – 0.08% 198
2015
Q2 		$1.97M Buy
22,320
+558
+3% +$51.2K 0.08% 247
2015
Q1 		$1.92M Sell
21,762
-1,674
-7% -$148K 0.09% 247
2014
Q4 		$1.95M Hold
23,436
– – 0.07% 215
2014
Q3 		$1.98M Buy
+23,436
New +$1.9M 0.05% 306
2014
Q2 		– Sell
-3,348
Closed -$255K – 873
2014
Q1 		$255K Sell
3,348
-70,308
-95% -$5.12M 0.01% 865
2013
Q4 		$5.3M Buy
+73,656
New +$5.12M 0.11% 229

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVS Position: Q2 2020 in Review

Weiss Multi-Strategy Advisers sold out of Novartis (NVS) in Q2 2020, closing a stake of 24,077 shares — an estimated $1.99M sold.

Weiss Multi-Strategy Advisers first reported a position in NVS in Q4 2013 and held it in 25 quarters. The position peaked at $5.3M in Q4 2013. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 24,077 Novartis shares in Q2 2020, an estimated $1.99M.
  • Weiss Multi-Strategy Advisers first reported a position in Novartis in Q4 2013 and held it in 25 quarters.
  • Weiss Multi-Strategy Advisers's Novartis position peaked at $5.3M in Q4 2013.
  • 1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.